Circulation, Vol 80, 807-815, Copyright © 1989 by American Heart Association
E Picano, S Pirelli, M Marzilli, F Faletra, F Lattanzi, L Campolo, D Massa, A Alberti, E Gara and A Distante
Seventy-four consecutive patients with angina undergoing single-lesion
percutaneous transluminal coronary angioplasty were evaluated with high-
dose (up to 0.84 mg/kg during 10 minutes) dipyridamole echocardiography
test (DET) before angioplasty and when possible, afterward. Angioplasty was
clinically or angiographically successful in 63 patients and unsuccessful
in 11. Before the procedure, 69 patients had a positive DET. Of these 69
patients, six with clinicall unsuccessful angioplasty had a dipyridamole
time (i.e., the time from the onset of dipyridamole infusion to development
of asynergy) lower than the 63 patients with clinically successfully
angioplasty (4.2 +/- 2.9 vs. 7.0 +/- 2.9 minutes, mean +/- SD, p less than
0.01). In the five patients with angiographically unsuccessful angioplasty
(residual stenosis diameter, greater than 50%), coronary stenosis decreased
from 89 +/- 10 to 69 +/- 22 (p = NS); DET was positive in all five before
and in four of the five after the procedure (100% vs. 80%, p = NS). In the
63 patients with angiographically successful angioplasty, coronary stenosis
diameter was reduced from 85 +/- 9% to 30 +/- 10% (p less than 0.01). DET
was positive in 58 patients before and in only 16 after the procedure (92%
vs. 25%, p less than 0.01). In the 16 patients with positive DET, before
and after angioplasty, dipyridamole time increased from 5.6 +/- 2.2 before
to 7.3 +/- 2.4 minutes immediately after the procedure (p less than 0.05).
After an average follow-up time of 10.8 +/- 5.9 months, angina recurred in
eight of 47 patients with negative DET after angioplasty and in 11 of 16
patients with positive DET (17% vs. 69%, p less than 0.01).(ABSTRACT
TRUNCATED AT 250 WORDS)
ARTICLES
Usefulness of high-dose dipyridamole echocardiography test in coronary angioplasty
Clinical Physiology Institute, CNR, University of Pisa, Italy.
This article has been cited by other articles:
![]() |
L. Cortigiani, E. Picano, P. Landi, M. Previtali, S. Pirelli, P. Bellotti, R. Bigi, O. Magaia, A. Galati, E. Nannini, et al. Value of pharmacologic stress echocardiography in risk stratification of patients with single-vessel disease: a report from the echo-persantine and echo-dobutamine international cooperative studies J. Am. Coll. Cardiol., July 1, 1998; 32(1): 69 - 74. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Dagianti, S. Rosanio, M. Penco, A. Dagianti, S. Sciomer, M. Tocchi, L. Agati, and F. Fedele Clinical and Prognostic Usefulness of Supine Bicycle Exercise Echocardiography in the Functional Evaluation of Patients Undergoing Elective Percutaneous Transluminal Coronary Angioplasty Circulation, March 4, 1997; 95(5): 1176 - 1184. [Abstract] [Full Text] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1989 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |